Obstructive sleep apnea is when breathing is repeatedly interrupted during sleep. Research has shown people with this sleep disorder have an increased risk of developing cognitive impairment and Alzheimer's disease. Yet, it is treatable. A preliminary study released today, February 28, 2021, has found that obstructive sleep apnea is common in people with cognitive impairment. The study will be presented at the American Academy of Neurology's 73rd Annual Meeting being held virtually April 17 to 22, 2021.
This study reported for the first time, which identified the gene mutations and abnormal splicing of PLCg1 gene in AD using both high-throughput screening data and a deep learning-based prediction (Splice-AI)
While physical activity is important for everyone, research has shown people with developmental disabilities do not exercise as often as their typically developed peers.
New research from Baylor College of Medicine scientists shows that a combination of deep brain stimulation (DBS) and exercise has potential benefits for treating ataxia, a rare genetic neurodegenerative disease characterized by progressive irreversible problems with movement.
Promising new research shows aerobic exercise may help slow memory loss for older adults living with Alzheimer's dementia.
Marilyn Rantz still remembers the day she got the call that her mother, whose health had been declining, had fallen and fractured her shoulder.
Heart problems cause disturbed gene activity in the brain's memory center, from which cognitive deficits arise. Researchers at the DZNE come to this conclusion based on laboratory studies. They consider that they have found a possible cause for the increased risk of dementia in people with heart problems.
A number of brain areas change their activity before we execute a planned voluntary movement. A new study by Umeå University identifies a novel function of this preparatory neural activity, highlighting another mechanism the nervous system can use to achieve its goals.
Curcumin is a polyphenol compound produced by plants of the Curcuma longa species and has been reported to have many physiological activities, including anti-oxidation, anti-inflammatory, anti-cancer, and anti-amyloid properties. This study demonstrates that curcumin is a PPARα/γ dual activator and may affect expression levels of proteins involved in amyloid deposition and other metabolism functions in a complex manner.
Scientists are still a long way from being able to treat Alzheimer's Disease, in part because the protein aggregates that can become brain plaques, a hallmark of the disease, are hard to study.